Laclare: Revolutionizing Presbyopia Care with €3.5 Million Seed Investment

In a significant development in the vision care sector, Laclare, a startup specializing in adaptive eyeglasses for presbyopia correction, has successfully raised €3.5 million in a seed funding round. The investment was led by Rimonci, a venture fund focused on vision care, alongside UI-Investissement and High-Tech Gründerfonds (HTGF). This round complements a €2.5 million grant from the EIC accelerator. Laclare's innovative product aims to revolutionize presbyopia correction by using autofocusing technology that mimics the eye’s natural focus ability. The capital influx will propel the company toward the development of its first commercial product by mid-2026. With eyeglasses that offer real-time distance adaptation and address common vision issues such as hyperopia and myopia, Laclare is poised to set new standards in eyewear solutions. The startup's eyeglasses have already demonstrated preference among users due to their advanced technology and seamless user experience. Laclare's CEO, Bruno Berge, emphasizes the company's commitment to meeting the needs of individuals affected by presbyopia, a condition that impacts 2 billion people worldwide. The investment aligns with the mission of Rimonci to support transformative technologies in vision care. With backing from prominent investors and support from European innovation frameworks, Laclare is positioned as a frontrunner in the development of cutting-edge vision solutions.